Eyegate Pharma (NQ: EYEG )
4.310
USD
+0.040
(+0.94%)
Official Closing Price
Updated: 5:25 PM EDT, Apr 16, 2021
Add to My Watchlist
All news about Eyegate Pharma
84 Biggest Movers From Yesterday
January 12, 2021
From Benzinga
63 Stocks Moving In Monday's Mid-Day Session
January 11, 2021
From Benzinga
From Benzinga
EyeGate Enters Into Agreement for $8.0 Million Private Placement
January 06, 2021
84 Biggest Movers From Yesterday
December 29, 2020
From Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
December 23, 2020
From Benzinga
42 Stocks Moving in Tuesday's Pre-Market Session
December 22, 2020
From Benzinga
82 Biggest Movers From Yesterday
December 22, 2020
From Benzinga
Mid-Afternoon Market Update: Dow Turns Positive; uniQure Shares Slide
December 21, 2020
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 21, 2020
From Benzinga
Mid-Day Market Update: Crude Oil Down 4%; 500.com Shares Spike Higher
December 21, 2020
From Benzinga
55 Stocks Moving In Monday's Mid-Day Session
December 21, 2020
From Benzinga
Thinking about buying stock in Verb Technology, Sundial Growers, Eyegate Pharmaceuticals, American Airlines, or Zomedica?
December 21, 2020
From PR Newswire
Mid-Morning Market Update: Markets Open Lower; FactSet Research Beats Q1 Estimates
December 21, 2020
From Benzinga
Analyzing The Price Action In Eyegate Pharmaceuticals Stock Today
December 21, 2020
From Benzinga
Biopharma M&A Continues: Agios Sells Oncology Portfolio, NantKwest's Reverse Merger With ImmunityBio, Eyegate Picks Up Panoptes
December 21, 2020
From Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Monday, Dec. 21, 2020: EYEG, NKE, ZM, WMT, AIM
December 21, 2020
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 21, 2020
From Benzinga
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
December 21, 2020
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
November 12, 2020
From Benzinga
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 10, 2020
From Benzinga
EyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business Update
November 09, 2020
From ACCESSWIRE
Stocks That Hit 52-Week Lows On Friday
November 06, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
EyeGate Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference
September 08, 2020
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.